Saturday, January 31, 2026

Biosimilars No Longer Second-Best: Highlighting Cost Savings and Improved Patient Access

Biosimilars are becoming standard care, with growing confidence in their safety and efficacy, driven by cost savings and improved accessibility.

From Curiosity to Contender: ChatGPT Search Takes Aim at Google in Europe

OpenAI's ChatGPT search function sees rapid growth in Europe, with MAUs reaching 41.3 million, posing a challenge to Google.

Tag: Illegal activities

No posts to display

Top News

- Our Sponsors Ad -

Follow us